Where Do You Inject Ozempic in the Thigh? A Comprehensive Guide

Last reviewed: June 22, 2026

Last updated: June 22, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide injections are administered subcutaneously once weekly, and the thigh represents one of three recommended injection sites along with the abdomen and upper arm. Proper injection technique ensures consistent drug absorption and reduces the risk of lipohypertrophy—localized fat tissue thickening that can develop from repeated injections in the same location. Understanding correct placement and method is essential for treatment success.

Anatomy of Safe Thigh Injection Sites

The outer thigh offers a large, accessible surface area ideal for subcutaneous injection of semaglutide. The injection zone extends from approximately 4 inches above the knee to 4 inches below the groin crease, and spans the outer third of the thigh where subcutaneous tissue sits directly beneath the skin. This anatomical region avoids major blood vessels and nerves while providing sufficient tissue depth for medication deposition.

Rotating injection sites across both thighs prevents tissue damage and maintains consistent medication absorption rates. Many patients establish a pattern—such as injecting the left thigh one week and the right thigh the next—to ensure adequate spacing between puncture sites. Within each thigh, moving injection locations at least one finger-width apart with each new injection minimizes discomfort and reduces the likelihood of developing hard lumps or scar tissue.

Step-by-Step Thigh Injection Technique

Begin by washing the injection site with soap and water or alcohol wipe and allowing it to air dry completely. Pinch a fold of skin on the outer thigh between your thumb and forefinger to create a raised area of tissue. With your other hand, hold the semaglutide pen or syringe at a 90-degree angle to the skin surface, then insert the needle quickly and smoothly through the skin into the subcutaneous layer.

Inject the medication steadily without forceful pressure, following your healthcare provider's timing recommendations for your specific dose. After injection, withdraw the needle at the same 90-degree angle and release the pinched skin. Apply gentle pressure with a clean gauze pad for 5-10 seconds if needed, though semaglutide typically produces minimal bleeding. Never rub the injection site, as this can increase bruising and alter absorption patterns.

Proper needle depth is critical—the needle should penetrate only into subcutaneous tissue, not muscle. A standard insulin needle (typically 4-6mm) inserted at 90 degrees achieves the correct depth in most patients. If you experience sharp pain during injection, stop immediately and reposition, as this may indicate contact with underlying muscle or nerve tissue.

Preventing Common Injection-Site Complications

Lipohypertrophy, characterized by thickened or lumpy tissue at injection sites, develops when the same area receives repeated injections over weeks or months. This complication impairs medication absorption and can cause visible skin changes. Systematic site rotation—changing locations with each weekly injection across multiple body areas—effectively prevents lipohypertrophy and maintains steady therapeutic levels of semaglutide.

Bruising and minor bleeding occur occasionally and typically resolve within days without intervention. To minimize bruising, avoid injecting into areas with existing bruises, apply ice for 5-10 minutes before injection if you have sensitive skin, and never inject through existing injection-site marks. If bruising becomes severe or persistent, inform your healthcare provider, as this may indicate improper technique or an underlying clotting disorder.

Pain during injection often stems from injecting into muscle rather than subcutaneous tissue or inserting the needle at an incorrect angle. Ensure the pinched skin fold is thick enough to accommodate the needle without penetrating deeper layers. If discomfort persists across multiple injection attempts, consult your provider about needle gauge adjustments or alternative injection techniques.

Why Thigh Injections Work for Long-Term Semaglutide Therapy

The thigh's subcutaneous tissue provides consistent absorption rates comparable to the abdomen, making it an equally effective injection site for semaglutide. The generous tissue area allows for multiple injection locations within a single limb, supporting extended rotation schedules that span weeks or months without repeating previous injection zones. This advantage makes thigh injections particularly valuable for patients on long-term weekly therapy.

PlexusDx's compounded semaglutide injections begin at $189/mo (or $149/mo on the 6-month plan) and follow a consistent monthly price regardless of dose progression—meaning your dose may increase as your body adapts, but your price remains stable. Proper injection technique, including rotating thigh sites systematically, ensures you receive maximum therapeutic benefit from each weekly dose. All PlexusDx medications come from licensed 503A compounding pharmacies and are available across all 50 states without insurance requirements, making consistent, high-quality semaglutide therapy accessible to patients nationwide.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($298) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers seven prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection is $189/mo month-to-month, or from $149/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $298 to personalize your protocol from day one.

Frequently Asked Questions

Can I inject semaglutide in the same thigh location every week?

No—rotating injection sites is essential to prevent lipohypertrophy and maintain consistent absorption. Inject the left thigh one week and the right thigh the next, and vary the specific location within each thigh with each injection. This systematic rotation protects tissue integrity and ensures reliable drug delivery throughout your treatment.

How deep should the needle go when injecting into the thigh?

A standard insulin needle (4-6mm) inserted at a 90-degree angle into pinched skin deposits medication in the subcutaneous layer without entering muscle. If you experience sharp or persistent pain, reposition the injection site immediately. Proper depth ensures medication absorption without nerve or muscle involvement.

Is thigh injection as effective as abdominal injection for semaglutide?

Yes—both the thigh and abdomen provide reliable subcutaneous absorption rates for semaglutide. Clinical data confirms equivalent bioavailability across these injection sites. Choose based on comfort and accessibility; many patients alternate between thigh and abdomen injections to maximize rotation options throughout their treatment course.

How does PlexusDx compounded semaglutide compare to the brand name?

PlexusDx semaglutide injections are $189/mo month-to-month, or from $149/mo on the 6-month plan and are produced in licensed 503A compounding pharmacies to pharmaceutical standards. All 50 states are served, no insurance is required, and pricing remains flat across dose increases. Your provider determines whether compounded or brand therapy suits your clinical needs.

Can genetic factors affect how I respond to semaglutide injections?

Yes—variants in the GLP1R rs6923761 gene and related peptide pathways influence semaglutide efficacy. PlexusDx's Precision Peptide Genetic Test ($298) maps 14 pathways and 150+ genetic insights, helping your provider personalize your dose and choose between semaglutide, tirzepatide, or dual-compound protocols based on your genetic predispositions.

Related Reading

• Lifemd Ozempic
• Eden Ozempic
• Ro Ozempic
• Mochi Ozempic

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.